What is the recommended ketamine and dexmedetomidine infusion protocol for total intravenous anesthesia (TIVA)?

Ketamine and Dexmedetomidine Infusion Protocol for TIVA

For total intravenous anesthesia (TIVA), use ketamine at an infusion rate of 0.1-0.5 mg/kg/h (after a 0.25 mg/kg bolus) combined with dexmedetomidine at 0.2-0.7 μg/kg/h (with or without a 0.5-1 μg/kg loading dose over 5-10 minutes), alongside propofol and an opioid for complete anesthetic coverage.

Ketamine Dosing for TIVA

According to FDA labeling, ketamine maintenance infusion for general anesthesia ranges from 0.1 to 0.5 mg/minute (approximately 0.1-0.5 mg/kg/h for a 70kg adult) 1. The FDA-approved protocol specifies:

• Induction: 1-4.5 mg/kg IV (average 2 mg/kg over 60 seconds), or 0.5 mg/kg/min infusion
• Maintenance: 0.1-0.5 mg/minute via slow microdrip infusion
• Must dilute 100 mg/mL concentration before IV use (mix 1:1 with sterile water, normal saline, or D5W)

For multimodal analgesia in surgical settings, evidence supports subanesthetic ketamine doses of boluses <0.35 mg/kg and infusions at 0.5-1 mg/kg/h 2. Recent research demonstrates that ketamine 0.5 mg/kg/h infusion combined with dexmedetomidine provides effective anesthesia with improved postoperative analgesia 3, 4.

Dexmedetomidine Dosing for TIVA

Multiple guidelines consistently recommend dexmedetomidine at 0.2-0.7 μg/kg/h for sedation and anesthesia 5, 6. Key dosing parameters:

• Loading dose: 0.5-1 μg/kg over 5-10 minutes (optional—avoid in hemodynamically unstable patients as it causes transient hypertension followed by hypotension and bradycardia) 5, 6
• Maintenance infusion: 0.2-0.7 μg/kg/h, can be increased up to 1.5 μg/kg/h as tolerated 6
• Onset: 5-15 minutes; peak effect: 1 hour 6

For postoperative analgesia combined with fentanyl PCA, use dexmedetomidine 0.07 μg/kg/h with 0.007 μg/kg bolus 2.

Combined Protocol Algorithm

Step 1: Premedication

• Administer antisialagogue (glycopyrronium 0.2-0.4 mg IV) to counteract ketamine-induced salivation 1

Step 2: Induction

• Propofol: 1-2 mg/kg IV for induction
• Ketamine: 0.25-0.5 mg/kg IV bolus (optional, for hemodynamic stability)
• Opioid: Remifentanil or fentanyl as needed

Step 3: Maintenance Infusion

• Propofol: 5-50 μg/kg/min (titrate to BIS 40-60 if available)
• Ketamine: 0.5 mg/kg/h continuous infusion 3, 4
• Dexmedetomidine: Start at 0.5 μg/kg/h (range 0.2-0.7 μg/kg/h) 3, 4, 7
  • Skip loading dose if patient is hemodynamically unstable
  • If loading dose used: 0.5-1 μg/kg over 10 minutes 5, 6
• Opioid: Remifentanil 1-3 ng/mL (TCI) or fentanyl boluses as needed

Step 4: Monitoring Requirements

• Continuous vital signs monitoring (mandatory per FDA) 1
• Emergency airway equipment immediately available
• Watch for hypotension and bradycardia (most common dexmedetomidine side effects) 6
• Monitor for respiratory depression (less common with this combination than with benzodiazepines)

Critical Advantages of This Combination

The ketamine-dexmedetomidine combination provides synergistic benefits:

• Ketamine maintains sympathetic tone and respiratory drive, counteracting dexmedetomidine's hypotensive/bradycardic effects 4, 8
• Dexmedetomidine provides anxiolysis and reduces emergence delirium from ketamine 9, 10
• Both agents have opioid-sparing effects, reducing total opioid consumption by 30-50% 2, 3
• Minimal respiratory depression compared to benzodiazepine-based protocols 6, 8
• Patients remain more arousable and cooperative 6, 11

Research shows this combination reduces postoperative pain scores, extends time to first analgesic requirement, and decreases total morphine consumption in the first 48 hours 3, 4, 7.

Important Caveats

Ketamine contraindications (per FDA): uncontrolled cardiovascular disease, pregnancy, active psychosis, severe liver dysfunction, elevated intracranial pressure, elevated intraocular pressure 2, 1.

Dexmedetomidine precautions:

• Causes biphasic cardiovascular response—initial hypertension (5-10 min) then hypotension (10-20% decrease) 12
• Bradycardia occurs commonly; have atropine available 6
• Reduce dose in severe hepatic dysfunction (prolonged emergence) 6

Propofol monitoring: Watch for propofol infusion syndrome (PRIS) with prolonged infusions >70 μg/kg/min—presents as metabolic acidosis, hypertriglyceridemia, hypotension, arrhythmias 6. Incidence ~1%, mortality up to 33% 6.

Avoid benzodiazepines as primary sedatives—they increase delirium risk and prolong emergence compared to this protocol 6, 11. Use only for emergence agitation if needed 1.

This protocol provides superior hemodynamic stability, reduced opioid requirements, and improved postoperative analgesia compared to traditional TIVA regimens 3, 4, 7.